Most cases involving patients undergoing total knee arthroplasty surgery are performed to repair damage to the knee joint caused by osteoarthritis. The cartilage between the bottom of the femur and top of the tibia wear away until the two bones rub against each other. This causes pain, making daily activities such as walking increasingly difficult and painful. Over 150,000 people have decided to have the Zimmer NexGen CR-Flex knee replacement surgically implanted to help reduce or eliminate the pain and restore their mobility.
Zimmer Inc. is one of the largest joint implant manufacturers in the world. They develop and sell a range of products designed to replace the knee joint. Unfortunately, a few have caused complications, including pain and loosening of the implant. Some patients affected by knee replacement problems have looked at their legal options including filing a Zimmer lawsuit knee claim.
From 2008 through 2009, Drs. Richard A. Berger and Craig Della Valle of Rush University in Chicago, Illinois reviewed 108 patients where a Zimmer NexGen CR-Flex femoral component was surgically implanted. At the American Academy of Orthopedic Surgeons (“AAOS”) in 2010, Dr. Berger reported that nine of his patients had to undergo revision surgery within two years of the original implant surgery due to early aseptic loosening. Revision surgery typically is performed when the femoral or tibial component have loosened to the point that they need to be replaced. Another 36 percent of the recipients also reported pain and loosening, which was confirmed with additional testing procedures.
The Food and Drug Administration (“FDA”) issued a Class II recall in September 2010 involving certain surgical techniques related to a specific tibial component Zimmer, Inc. designed and manufactured for use in relation to a NexGen High-Flex knee replacement. This recall is only for a specific knee component associated with Zimmer’s knee products. Some knee surgery patients have reported having problems involving the Zimmer knee. It is estimated that since 2003, the NexGen CR-Flex and LPS-Flex knee replacement has been implanted in more than 150,000 patients. Additionally, Zimmer sold approximately 68,000 units of the tibial plate affected by the FDA recall worldwide. A number of patients have already reported having knee replacement complications and problems including: serious or ongoing pain, infection, swelling and loosening or dislocation of the knee implant or components.
Finally, in December of 2010, the FDA announced a second recall involving certain component parts associated with several Zimmer knee replacement parts including the NexGen LPS-Flex. The recall involved manufacturing problems associated with the NexGen LPS-Flex that could result in premature failure.
Nationwide Zimmer Nexgen Lawsuit Representation
We represent all patients subject to the FDA recall of the Zimmer tibial plate, those who received a NexGen CR-Flex during their surgery and those who received a NexGen LPS-Flex knee on a contingency basis. This means that there are never any legal fees unless we win compensation in your case. If you are experiencing problems, including pain or loosening, particularly with the tibial plate component of the implant please contact us.
For a free no-obligation consultation please call toll free or fill out our short online contact form and a Zimmer NexGen knee lawsuit attorney will contact you to answer any of your questions including the latest Zimmer lawsuit news.
There are never any legal fees or expenses unless you receive compensation